Conceicao Bettencourt

researcher

Conceicao Bettencourt is …
instance of (P31):
humanQ5

External links are
P7893CIÊNCIAVITAE ID2817-9D2F-4C9B
P2671Google Knowledge Graph ID/g/11f0zvtp1y
P496ORCID iD0000-0001-9090-7690
P1153Scopus author ID8581587200
P4012Semantic Scholar author ID2629076

P69educated atUniversity of the AzoresQ1461089
P108employerUniversity College LondonQ193196
Complutense University of MadridQ219694
VU University Medical CenterQ1888218
Hospital do Divino Espírito SantoQ30294654
Institute for Molecular and Cell BiologyQ10302765
P734family nameBettencourtQ16143019
BettencourtQ16143019
BettencourtQ16143019
P735given nameC.Q19803499
C.Q19803499
P1412languages spoken, written or signedEnglishQ1860
PortugueseQ5146
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q86136487"Mimicking" capacity of spinocerebellar ataxia type 3: the details matter
Q52149799A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease.
Q47637817A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea
Q47358966A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function.
Q91841215AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Q52573208Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease.
Q43800477Analysis of segregation patterns in Machado-Joseph disease pedigrees.
Q37364099Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features
Q86538975Clinical and Neuropathological Features of Spastic Ataxia in a Spanish Family with Novel Compound Heterozygous Mutations in STUB1
Q35928302Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.
Q44436182Cross-sectional study of risk factors for atherosclerosis in the Azorean population.
Q42371425Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Q47140619Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Q47145203Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Q94918069Epigenomics and transcriptomics analyses of multiple system atrophy brain tissue supports a role for inflammatory processes in disease pathogenesis
Q46340410Exome sequencing is a useful diagnostic tool for complicated forms of hereditary spastic paraplegia.
Q53842374Exome sequencing uncovers hidden pathways in familial and sporadic ALS.
Q92583431Expanding the Phenotype and Genetic Defects Associated with the GOSR2 Gene
Q34506653Gene co-expression networks shed light into diseases of brain iron accumulation
Q38579944Genetic advances in sporadic inclusion body myositis.
Q38787523Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.
Q37081945Genetic and phenotypic characterization of complex hereditary spastic paraplegia
Q33481055Genetic profiling of the Azores Islands (Portugal): data from 10 X-chromosome STRs.
Q47106032Genotype-phenotype correlations and expansion of the molecular spectrum of AP4M1-related hereditary spastic paraplegia.
Q57707777Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3
Q112293594In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
Q104583296MOBP and HIP1 in multiple system atrophy: new α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis
Q21202868Machado-Joseph Disease: from first descriptions to new perspectives.
Q47309944Multiple system atrophy: genetic risks and alpha-synuclein mutations.
Q37514583Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3).
Q90931246Paroxysmal Movement Disorder and Epilepsy Caused by a De Novo Truncating Mutation in KAT6A
Q37127064Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases
Q46318225Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease.
Q52805127Polymorphism of the APOE locus in the Azores Islands (Portugal).
Q28286077Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal
Q60819797Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients
Q36408106Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation
Q37592782Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.
Q52152081Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid?
Q52804580Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).
Q57949688Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)
Q47841461Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset.
Q33806912Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.
Q41736716The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Q59199944The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease
Q50303809The African contribution to the present-day population of the Azores Islands (Portugal): analysis of the Y chromosome haplogroup E.
Q35230251The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis
Q84394600Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions
Q34258022Trehalose improves human fibroblast deficits in a new CHIP-mutation related ataxia.
Q34478330Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.
Q47282280Understanding differences between phylogenetic and pedigree-derived mtDNA mutation rate: a model using families from the Azores Islands (Portugal).
Q90173335White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy

The articles in Wikimedia projects and languages

      Conceição Bettencourtwikipedia

Search more.